Neurocrine Biosciences



Ebitda Cambio Fecha
AbbVie USD 4.4B 2.52B 2025-03
Acadia Pharmaceuticals USD 35.31M 13.07M 2025-06
Agios Pharmaceuticals USD -125797000 20.45M 2025-06
ALKERMES USD 126.53M 105.32M 2025-06
Alnylam Pharmaceuticals USD 18.83M 13.65M 2025-06
Amgen USD 3.6B 147M 2025-06
Biogen USD 1.01B 456.5M 2025-06
BioMarin Pharmaceutical USD 295.45M 49.49M 2025-06
Cytokinetics USD -153331000 16.67M 2025-03
Dynavax Technologies USD -21594000 22.03M 2025-03
Exelixis USD 220.92M 26.71M 2025-06
Gilead Sciences USD 3.4B 797M 2025-06
Halozyme Therapeutics USD 225.5M 63.51M 2025-06
Incyte USD 581.52M 358.87M 2025-06
Ionis Pharmaceuticals USD 150.23M 291.7M 2025-06
Neurocrine Biosciences USD 152.9M 121.6M 2025-06
Pfizer USD 5.32B 889M 2025-06
Prothena USD -51782000 12.89M 2025-06
Regeneron Pharmaceuticals USD 1.66B 926.5M 2025-06
Repligen USD 32.18M 9.36M 2025-06
Sarepta Therapeutics USD 126.42M 416.82M 2025-06
Teva Pharmaceutical Industries USD 1.23B 124M 2025-06
Ultragenyx Pharmaceutical USD -91344000 35.09M 2025-06
Vertex Pharmaceuticals USD 1.34B 556.6M 2025-06


Neurocrine Biosciences - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Sep 2025.